In Brief

According to BCC Research, the global single-use technology market will reach over $4.3 billion by 2021. The most significant increase will be in the highly adaptable disposable mixing system segment. Mixing systems are used in every form of biopharmaceutical production as well as through stages of testing. 

In Brief

A wound can be described or defined in many ways: by its source, anatomical location and appearance, whether acute or chronic, by presenting symptoms, and by the method of closure. In fact, all of these descriptions serve a critical purpose in the assessment and appropriate treatment and management of the wound. Successful wound management seeks symptom resolution and, if viable, complete healing. Managing skin wound care involves supporting the damaged tissue by promoting restoration through the formation of connective tissue and re-growth of the epithelium. Optimum conditions for wound healing involve creating a desirable micro-environment in which an ideal moisture content is one of the most important factors.

In Brief

In the early days of disposable medical devices, the biopharmaceutical industry manufactured single-use films made with "off-the-shelf" materials borrowed from other industries, such as food. Over the years, various experiences and research into the safety of medical grade materials have taught manufacturers that using materials not specifically designed and intended for use with pharmaceuticals was not the wisest choice.

In Brief

Flexible materials combined with emerging technologies are at the forefront of healthcare innovations. Guiding recent advances are cost concerns, mass-production, and improved patient outcomes.

In Brief

In wound care management, the primary objective is complete healing. This is attained through thoughtful planning of patient care for reducing the loss of necessary fluids from the wound, accelerating wound healing, and minimizing pain and infection.